Integrated Filing — IndAS

General information about company
Scrip Code	532705
NSE Symbol	JAGRAN
MSEI Symbol	NOTLISTED
ISIN	INE199G01027
Name of company	JAGRAN PRAKASHAN LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	24-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	14-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Printing, Publishing and Others
Start date and time of board meeting	24-May-2025   14:30:00
End date and time of board meeting	24-May-2025   16:15:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	2022-02-08
Indicate Company website link for updated RPT policy of the Company	https://jplcorp.in/new/pdf/Policy_on_Related_Party_Transactions.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
Not Applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	4106250000	15898396000
	Other income	265087000	767708000
	Total income	4371337000	16666104000
2	Expenses
(a)	Cost of materials consumed	1037864000	4068534000
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	0	0
(d)	Employee benefit expense	849809000	3299938000
(e)	Finance costs	21179000	88595000
(f)	Depreciation, depletion and amortisation expense	141326000	527283000
(f)	Other Expenses
1	Imapirment of Investment in Subsidiary	36044000	36044000
2	Net Impairment Losses on Financial Assets	34776000	223024000
3	Other Expenses	1435161000	5544315000
	Total other expenses	1505981000	5803383000
	Total expenses	3556159000	13787733000
3	Total profit before exceptional items and tax	815178000	2878371000
4	Exceptional items	0	0
5	Total profit before tax	815178000	2878371000
6	Tax expense
7	Current tax	188458000	681375000
8	Deferred tax	25828000	85835000
9	Total tax expenses	214286000	767210000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	600892000	2111161000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	600892000	2111161000
17	Other comprehensive income net of taxes	-27437000	-27437000
18	Total Comprehensive Income for the period	573455000	2083724000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	435309000	435309000
	Face value of equity share capital	2	2
27	Details of debt securities
22	Reserves excluding revaluation reserve		16591966000
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	2.76	9.7
	Diluted earnings (loss) per share from continuing operations	2.76	9.7
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	2.76	9.7
	Diluted earnings (loss) per share from continuing and discontinued operations	2.76	9.7
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		For Notes please refer the Statement of Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2025 filed on the portal of Stock Exchanges in pdf format.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	2714250000
	Capital work-in-progress	89304000
	Investment property	158655000
	Goodwill	2293729000
	Other intangible assets	11589000
	Intangible assets under development	31500000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	2850519000
	Non-current financial assets
	Non-current investments	1719985000
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	251307000
	Total non-current financial assets	1971292000
	Deferred tax assets (net)	0
	Other non-current assets	232305000
	Total non-current assets	10353143000
2	Current assets
	Inventories	574177000
	Current financial asset
	Current investments	5634119000
	Trade receivables, current	3491412000
	Cash and cash equivalents	456176000
	Bank balance other than cash and cash equivalents	621925000
	Loans, current	26558000
	Other current financial assets	559197000
	Total current financial assets	10789387000
	Current tax assets (net)	0
	Other current assets	563560000
	Total current assets	11927124000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	22280267000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	435309000
	Other equity	16591966000
	Total equity attributable to owners of parent	17027275000
	Non controlling interest
	Total equity	17027275000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	393146000
	Total non-current financial liabilities	393146000
	Provisions, non-current	152079000
	Deferred tax liabilities (net)	1112922000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	1658147000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	10292000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1148901000
	Total Trade payable	1159193000
	Other current financial liabilities	1322841000
	Total current financial liabilities	2482034000
	Other current liabilities	1025294000
	Provisions, current	87517000
	Current tax liabilities (Net)	0
	Deferred government grants, Current	0
	Total current liabilities	3594845000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	5252992000
	Total equity and liabilites	22280267000
	Disclosure of notes on assets and liabilities	Textual Information(1)

Text Block
Textual Information(1)	For Notes please refer the Statement of Standalone and Consolidated Audited Financial Results for the quarter and year ended March 31, 2025 filed on the portal of Stock Exchanges in pdf format.

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Remeasurements of post-employment benefit obligations	-36665000	-36665000
	Total Amount of items that will not be reclassified to profit and loss	-36665000	-36665000
2	Income tax relating to items that will not be reclassified to profit or loss	-9228000	-9228000
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss
5	Total Other comprehensive income	-27437000	-27437000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Standalone
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			2878371000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			0
	Adjustments for decrease (increase) in inventories			-97848000
	Adjustments for decrease (increase) in trade receivables, current			170428000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			14009000
	Adjustments for decrease (increase) in other non-current assets			2094000
	Adjustments for other financial assets, non-current			0
	Adjustments for other financial assets, current			-66181000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			-294168000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			52797000
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			527283000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			0
	Adjustments for provisions, current			-54911000
	Adjustments for provisions, non-current			0
	Adjustments for other financial liabilities, current			18910000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-443000
	Adjustments for dividend income			351000
	Adjustments for interest income			258569000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-349591000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			0
	Other adjustments for non-cash items			0
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			-336541000
	Net cash flows from (used in) operations			2541830000
	Dividends received			0
	Interest paid			-88595000
	Interest received			0
	Income taxes paid (refund)			719067000
	Other inflows (outflows) of cash			145777000
	Net cash flows from (used in) operating activities			2057135000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			92900000
	Purchase of property, plant and equipment			421248000
	Proceeds from sales of investment property			135919000
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			0
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			351000
	Interest received			299155000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-180624000
	Net cash flows from (used in) investing activities	-73547000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			750000000
	Payments of lease liabilities			130175000
	Dividends paid			1086343000
	Interest paid			127906000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-2094424000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			-110836000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			0
	Net increase (decrease) in cash and cash equivalents			-110836000
	Cash and cash equivalents cash flow statement at beginning of period			0
	Cash and cash equivalents cash flow statement at end of period			-110836000